Wastewater Surveillance of SARS-CoV-2 across 40 U.S. states.


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
14 Mar 2021
Historique:
pubmed: 25 3 2021
medline: 25 3 2021
entrez: 24 3 2021
Statut: epublish

Résumé

Wastewater-based disease surveillance is a promising approach for monitoring community outbreaks. Here we describe a nationwide campaign to monitor SARS-CoV-2 in the wastewater of 159 counties in 40 U.S. states, covering 13% of the U.S. population from February 18 to June 2, 2020. Out of 1,751 total samples analyzed, 846 samples were positive for SARS-CoV-2 RNA, with overall viral concentrations declining from April to May. Wastewater viral titers were consistent with, and appeared to precede, clinical COVID-19 surveillance indicators, including daily new cases. Wastewater surveillance had a high detection rate (>80%) of SARS-CoV-2 when the daily incidence exceeded 13 per 100,000 people. Detection rates were positively associated with wastewater treatment plant catchment size. To our knowledge, this work represents the largest-scale wastewater-based SARS-CoV-2 monitoring campaign to date, encompassing a wide diversity of wastewater treatment facilities and geographic locations. Our findings demonstrate that a national wastewater-based approach to disease surveillance may be feasible and effective.

Identifiants

pubmed: 33758888
doi: 10.1101/2021.03.10.21253235
pmc: PMC7987047
pii:
doi:

Types de publication

Preprint

Langues

eng

Commentaires et corrections

Type : UpdateIn

Déclaration de conflit d'intérêts

Competing Interests MM and NG are cofounders of Biobot Analytics. EJA is advisor to Biobot Analytics. CD, KAM, KF, and NE are employees at Biobot Analytics, and all these authors hold shares in the company.

Auteurs

Fuqing Wu (F)

Department of Biological Engineering, Massachusetts Institute of Technology.
Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology.

Amy Xiao (A)

Department of Biological Engineering, Massachusetts Institute of Technology.
Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology.

Jianbo Zhang (J)

Department of Biological Engineering, Massachusetts Institute of Technology.
Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology.

Katya Moniz (K)

Department of Biological Engineering, Massachusetts Institute of Technology.
Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology.

Noriko Endo (N)

Biobot Analytics, Inc., Cambridge, MA.

Federica Armas (F)

Singapore-MIT Alliance for Research and Technology, Antimicrobial Resistance Interdisciplinary Research Group, Singapore.
Campus for Research Excellence and Technological Enterprise (CREATE), Singapore.

Mary Bushman (M)

Harvard T.H. Chan School of Public Health, Harvard University.

Peter R Chai (PR)

Division of Medical Toxicology, Department of Emergency Medicine, Brigham and Women's Hospital, Harvard Medical School.
The Fenway Institute, Fenway Health, Boston, MA.

Claire Duvallet (C)

Biobot Analytics, Inc., Cambridge, MA.

Timothy B Erickson (TB)

Division of Medical Toxicology, Department of Emergency Medicine, Brigham and Women's Hospital, Harvard Medical School.
The Koch Institute for Integrated Cancer Research, Massachusetts Institute of Technology.
Harvard Humanitarian Initiative, Harvard University.

Katelyn Foppe (K)

Biobot Analytics, Inc., Cambridge, MA.

Newsha Ghaeli (N)

Biobot Analytics, Inc., Cambridge, MA.

Xiaoqiong Gu (X)

Singapore-MIT Alliance for Research and Technology, Antimicrobial Resistance Interdisciplinary Research Group, Singapore.
Campus for Research Excellence and Technological Enterprise (CREATE), Singapore.

William P Hanage (WP)

Harvard T.H. Chan School of Public Health, Harvard University.

Katherine H Huang (KH)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Wei Lin Lee (WL)

Singapore-MIT Alliance for Research and Technology, Antimicrobial Resistance Interdisciplinary Research Group, Singapore.
Campus for Research Excellence and Technological Enterprise (CREATE), Singapore.

Mariana Matus (M)

Biobot Analytics, Inc., Cambridge, MA.

Kyle A McElroy (KA)

Biobot Analytics, Inc., Cambridge, MA.

Steven F Rhode (SF)

Massachusetts Water Resources Authority, Boston, MA.

Stefan Wuertz (S)

Campus for Research Excellence and Technological Enterprise (CREATE), Singapore.
Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore.
Civil and Environmental Engineering, Nanyang Technological University, Singapore.

Janelle Thompson (J)

Campus for Research Excellence and Technological Enterprise (CREATE), Singapore.
Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore.
Asian School of the Environment, Nanyang Technological University, Singapore.

Eric J Alm (EJ)

Department of Biological Engineering, Massachusetts Institute of Technology.
Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology.
Singapore-MIT Alliance for Research and Technology, Antimicrobial Resistance Interdisciplinary Research Group, Singapore.
Campus for Research Excellence and Technological Enterprise (CREATE), Singapore.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Classifications MeSH